People · Operator

Jaye Connolly

Named in public records as an officer, director or promoter · active 2009–2013 · Other Health Care

2
Companies
2
Filings
$16.6M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Independa, Inc.Other Health CareSeries A$13.6M$28.3M2013
A-Life Medical, Inc.Other Health CareSeed$3.0M$74.4M2009
Operator network

Jaye Connolly at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Magda Marquet · 6 companies · 1 sharedMagda MarquetAndrew Arno · 3 companies · 1 sharedAndrew ArnoGene Barduson · 2 companies · 1 sharedGene BardusonJohn Carrington · 2 companies · 1 sharedJohn CarringtonJon Sundt · 2 companies · 1 sharedJon SundtAndy Arno · 1 companies · 1 sharedAndy ArnoGary Gilmore · 1 companies · 1 sharedGary GilmoreKian Saneii · 1 companies · 1 sharedKian SaneiiRichard Della Penna · 1 companies · 1 sharedRichard Della Pen…Tim Carpenter · 1 companies · 1 sharedTim CarpenterZach Hornby · 1 companies · 1 sharedZach HornbyJAMES T CALLIER · 1 companies · 1 sharedJAMES T CALLIERROBERT M JAFFE · 1 companies · 1 sharedROBERT M JAFFETOM BANG · 1 companies · 1 sharedTOM BANGIndependa, Inc. · $13.6M raisedIndependa, Inc.A-Life Medical, Inc. · $3.0M raisedA-Life Medical, Inc.Jaye ConnollyJC
Jaye Connolly Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Jaye Connolly on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Magda Marquet16
Andrew Arno13
Jon Sundt12
Gene Barduson12
John Carrington12
Tim Carpenter11
Gary Gilmore11
ROBERT M JAFFE11
TOM BANG11
JAMES T CALLIER11
Kian Saneii11
Richard Della Penna11
Zach Hornby11
Andy Arno11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.